PIK3CA,PIK3CB双重抑制联合利妥昔单抗在DLBCL靶向治疗中的作用及机制研究
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | Clinicopathological significance of miR-101-3p and c-myc mRNA expression in diffused large B-cell lymphoma | 期刊论文 | Wenli Cui;Xingyan Zhang;Shutao Zheng;Zhiping Ma;Xuelian Pang;Xinxia Li |
2 | Clinicopathological and molecular genetic abnormalities associated with the prognosis of angioimmunoblastic T-cell lymphoma | 期刊论文 | Zhiping Ma;Gulinaer Abulajiang;Xuelian Pang;Yi Shi;Wei Zhang;Xinxia Li;Wenli Cui |
3 | 病理取材盒 | 专利 | 崔文丽;张巍;李新霞;马遇庆;郑树涛;庞雪莲;马志萍;周剑 |
4 | PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro | 期刊论文 | Wenli Cui;Shutao Zheng;Zebing Liu;Weige Wang;Ying Cai;Rui Bi;Bing Cao;Xiaoyan Zhou |
5 | PIK3CA amplification and PTEN loss in diffused large B-Cell lymphoma | 期刊论文 | Wenli Cui;Mingfu Ma;Shutao Zheng;Zhiping Ma;Liping Su;Wei Zhang |